Jianxiang Wang - Publications, H-index & Citations

王

王建祥 (Jianxiang Wang)

xi'an jiaotong university

57H指数

846论文数

1.8W被引数

收录论文 186

发表时间

Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance 荧光标记的Angiopep-2共轭-PAMAM纳米粒子用于评估药物脑靶向递送性能

Nanomedicine

IF3.9

2026-09-02

PREAI

Xingyue Li; Jianxiang Wang; Yifei Wang; Fangfang Hu; Xin Yang; Jingjing Zhang; Haiyan Dong; Wen Lu

Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study Asciminib在针对东亚新诊断慢性髓系白血病患者的关键性ASC4FIRST研究亚组分析中，相较于研究者选择的酪氨酸激酶抑制剂，显示出更好的疗效和更佳的安全性及耐受性

Cancer Medicine

IF3.1

2026-06-24

OAAI

Naoto Takahashi; Dong-Wook Kim; Inho Kim; Xin Du; Sung-Eun Lee; Yu Hu; Yoshikane Kikushige; Qian Jiang; Yi Wang; Suning Chen; Huanling Zhu; Tatsunori Goto; Akihiro Tomita; Michiko Ichii; Hirohisa Nakamae; Lei Liu; Beini Liu; Kamel Malek; Tong Zhu; Shengyuan Wu; Jianxiang Wang

Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia 维奈克拉联合儿科方案在Ph阴性急性淋巴细胞白血病青少年和成人患者中的应用

Blood

IF23.1

2026-05-25

PREAI

Xiaoyuan Gong; Yuntao Liu; Qiuyun Fang; Runxia Gu; Kaiqi Liu; Dong Lin; Chunlin Zhou; Guangji Zhang; Benfa Gong; Shuning Wei; Yan Li; Shouyun Li; Ying Wang; Shaowei Qiu; Bingcheng Liu; Ying Wang; Yingchang Mi; Hui Wei; Jianxiang Wang

Author Correction: Proteasome-guided haem signalling axis contributes to T cell exhaustion 作者更正：蛋白酶体引导的血红素信号轴有助于T细胞耗竭

Nature

IF48.5

2026-05-07

PREAI

Yingxi Xu; Yangtao Shangguan; Yu-Ming Chuang; Tzu-Hsuan Chang; Wenbing Liu; Jhan-Jie Peng; Josep Garnica; Leling Xie; Pei-Chun Hsueh; Mei-Chun Lin; Yi-Hao Wang; Karina Lobo Hajdu; Yibo Wu; Maryam Akrami; Chen Wang; Anna Kohl; Alfred Zippelius; Wei Qi; Min Wang; Bugi Ratno Budiarto; Shih-Yu Chen; Zhengtao Xiao; Panagiota Vardaka; Rahul Roychoudhuri; Zhiliang Bai; Rong Fan; Santiago Carmona; Yi-Ru Yu; Christoph Scheiermann; Jianxiang Wang; Ping-Chih Ho

Daunorubicin-45 Vs. Daunorubicin-60 for Induction in Intermediate-Age Patients of AML: Results From a Randomized Trial 柔红霉素-45与柔红霉素-60用于中老年急性髓系白血病诱导治疗：一项随机试验的结果

Cancer Science

IF4.3

2026-04-15

OAAI

Chunlin Zhou; Le Li; Yan Li; Kaiqi Liu; Yuntao Liu; Dong Lin; Benfa Gong; Guangji Zhang; Xiaoyuan Gong; Qiuyun Fang; Bingcheng Liu; Shaowei Qiu; Ying Wang; Hui Wei; Yingchang Mi; Jianxiang Wang

Active Rac1-Mediated Bone Marrow Retention Enhances CD33 CAR-T Cell Efficacy Against CD33+ Leukemia Cells 活性Rac1介导的骨髓滞留增强CD33 CAR-T细胞对CD33+白血病细胞的疗效

the faseb journal

IF0

2026-04-10

PREAI

Shangshang Wang; Le Li; Haiyan Xing; Yingxi Xu; Zhifeng Yan; Haotian Ma; Heye Yu; Fan Ding; Kejing Tang; Zheng Tian; Shaowei Qiu; Ying Wang; Min Wang; Qing Rao; Runxia Gu; Jianxiang Wang

Quizartinib in newly diagnosed patients with FLT3-ITD–positive AML who received maintenance therapy in QuANTUM-First Quizartinib在QuANTUM-First研究中，接受维持治疗的初诊FLT3-ITD阳性AML患者中的应用

Blood Advances

IF7.1

2026-04-09

OAAI

Mark J. Levis; Harry P. Erba; Pau Montesinos; Elżbieta Patkowska; Jorge Cortes; Alexander E. Perl; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Li Liu; Yasser Mostafa Kamel; Karima Imadalou; Abderrahmane Laadem; Kristy Burns; Mikkael A. Sekeres

Qingwen Baidu Decoction attenuates acute lung injury via macrophage exosomal miR-146a suppression of alveolar epithelial cell pyroptosis 百草清瘟散通过巨噬细胞外泌体miR-146a抑制肺泡上皮细胞焦亡来减轻急性肺损伤

Journal of Traditional and Complementary Medicine

IF3

2026-04-09

OAAI

Qiong Yi; Jianxiang Wang; Yaqing Jiang; Binbin Zhang; Shuxu Tan; Meilan Hu; Feiyue Dai; Qinghua Peng

Proteasome-guided haem signalling axis contributes to T cell exhaustion 蛋白酶体引导的血红素信号轴有助于T细胞耗竭

Nature

IF48.5

2026-03-18

PREAI

Phase 1 trial of BCL-2 inhibitor lisaftoclax (APG-2575) in Chinese patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma and other non-Hodgkin lymphomas BCL-2抑制剂lisaftoclax（APG-2575）在中国复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤及其他非霍奇金淋巴瘤患者中的I期临床试验

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2026-03-17

PREAI

Mingyuan Sun; Keshu Zhou; Junyuan Qi; Huilan Liu; Aizong Shen; Liangquan Geng; Fuling Zhou; Jianying Huang; Zi Chen; Ke Zhang; Lichuang Men; Danhua Cong; Fang Lu; Dajun Yang; Yifan Zhai; Jianxiang Wang

Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial

Annals of Hematology

IF2.4

2026-01-12

OAAI

Bin Jiang; Jian Li; Ligen Liu; Xin Du; Hao Jiang; Jianda Hu; Xiaoxi Zeng; Taishi Sakatani; Masanori Kosako; Yaru Deng; Vladimir Ivanov; Sergey Bondarenko; Lily Wong Lee Lee; Archrob Khuhapinant; Elena Martynova; Nahla Hasabou; Jamie Jung-Hee An; Jianxiang Wang

Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia FLT3-ITD的克隆结构和获得性13q单亲二倍体的定义了急性髓系白血病中的预后异质性和治疗易损性。

Neoplasia

IF7.7

2025-12-17

OAAI

Anli Lai; Wenbing Liu; Yihan Mei; Qimin Zhang; Junping Zhang; Kejing Tang; Qing Rao; Runxia Gu; Sizhou Feng; Ying Wang; Min Wang; Hui Wei; Yingchang Mi; Shaowei Qiu; Jianxiang Wang

Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in ASC4FIRST Asciminib在asc4首先在新诊断的慢性粒细胞白血病中表现出优异的疗效和安全性

Blood

IF23.1

2025-12-17

OAAI

Jorge E. Cortes; Timothy P. Hughes; Jianxiang Wang; Dong-Wook Kim; Dennis Dong Hwan Kim; Jiri Mayer; Yeow-Tee Goh; Philipp le Coutre; Gabriel Etienne; Inho Kim; David J. Andorsky; Felice Bombaci; Ghayas C. Issa; Naoto Takahashi; Shruti Kapoor; Rajendra Jinwal; Kamel Malek; Tracey McCulloch; Lillian Yau; Richard A. Larson

Measurable residual disease recurrence as early warning of relapse in acute myeloid leukemia

HAEMATOLOGICA

IF7.9

2025-12-01

OAAI

Gong, Benfa; Yang, Miao; Qiu, Shaowei; Liu, Bingcheng; Wang, Ying; Mi, Yingchang; Wei, Hui; Wang, Jianxiang

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy 低剂量阿糖胞苷和维奈克拉在不符合强化疗条件的急性髓系白血病患者中的风险分层

Blood Advances

IF7.1

2025-11-24

OAAI

Andrew H. Wei; Panayiotis Panayiotidis; Pau Montesinos; Kamel Laribi; Vladimir Ivanov; Inho Kim; Jan Novak; Rebecca Champion; Walter Fiedler; Maria Pagoni; Julie Bergeron; Stephen B. Ting; Jing-Zhou Hou; Takahiro Yamauchi; Jianxiang Wang; Stephen A. Strickland; Michael R. Savona; Tara L. Lin; Anoop Enjeti; Ing Soo Tiong

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients 低水平异常B淋巴母细胞在慢性髓系白血病患者中的进展意义

Clinical and Translational Medicine

IF6.8

2025-11-05

OAAI

Haoren Wang; Huijun Wang; Yuanyuan Li; Bin Zheng; Qiuyun Fang; Yan Li; Yuntao Liu; Runxia Gu; Ying Wang; Yingchang Mi; Bingcheng Liu; Hui Wei; Jianxiang Wang

Does Corporate ESG Performance Enhance Sustained Green Innovation? Empirical Evidence from China 企业ESG绩效是否提升可持续绿色创新？来自中国的实证证据

ECONOMICS-THE OPEN ACCESS OPEN-ASSESSMENT E-JOURNAL

IF1.2

2025-10-15

PREAI

Wang, Xueqing; Shi, Yongdong; Wang, Jianxiang; Wang, Guiliang; Wei, Zeshuai; Li, Jingyi

FLT3-ITD measurable residual disease from the QuANTUM-First trial FLT3-ITD可测量残留病灶来自QuANTUM-First试验

Blood Advances

IF7.1

2025-10-08

OAAI

Mark J. Levis; Harry P. Erba; Pau Montesinos; Hee-Je Kim; Radovan Vrhovac; Elżbieta Patkowska; Pavel Žák; Po-Nan Wang; Jaime E. Connolly Rohrbach; Ken C.N. Chang; Li Liu; Yasser Mostafa Kamel; Karima Imadalou; Arnaud Lesegretain; Jorge Cortes; Mikkael A. Sekeres; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Alexander E. Perl

Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study 中国急性白血病亚型在不同年龄组的发病率、死亡率和生存率：一项基于人群癌症登记的分析和队列研究

The Lancet Haematology

IF0

2025-10-06

PREAI

Wei Yin; Xiaoyu Yan; Jiaoyang Cai; Bingfeng Han; Peng Yin; Gang Lu; Wenyan Cheng; Jianan Zhang; Huiyi Wu; Jiaqi Ren; Pengyu Ren; Zifang Zhou; Haibo Wang; Ying Shi; Lanxia Gan; Depei Wu; Jie Jin; Yongping Song; Zhongxing Jiang; Xiaojing Yan; Ting Niu; Yu Hu; Fei Li; Sujun Gao; Tao Cheng; Jianxiang Wang; Xi Zhang; Xiaojun Huang; Qifa Liu; Xiaoyu Zhu; Pengcheng He; Yuqing Chen; Tonghua Yang; Jianyong Li; Xudong Wei; Yongrong Lai; Jishi Wang; Jinsong Yan; Jie Yu; Xiaofan Zhu; Weiqun Xu; Yufeng Liu; Ju Gao; Hua Jiang; Yongzhi Zheng; Hua Wang; Yunyan He; Yongjun Fang; Shuhong Shen; Jing Chen; Bing Chen; Sujiang Zhang; Yang Shen; Jin Wang; Jianqing Mi; Weili Zhao; Hao Zhang; Maigeng Zhou; Wenqiang Wei; Jie He; Zhu Chen; Sai-Juan Chen

Clinical characteristics and therapeutic determinants of RUNX1::RUNX1T1 differ from those of CBFB::MYH11 acute myeloid leukemia RUNX1::RUNX1T1的临床特征和治疗决定因素与CBFB::MYH11急性髓系白血病不同。

HAEMATOLOGICA

IF7.9

2025-10-01

OAAI

Yang, Miao; Wang, Wenting; Zhang, Guangji; Qiu, Shaowei; Liu, Bingcheng; Mi, Yingchang; Wang, Ying; Wang, Jianxiang; Wei, Hui

研究方向